ACADIAN ASSET MANAGEMENT LLC - ALIGOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ALIGOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$420
-23.2%
564,7150.0%0.00%0.0%
Q2 2023$547
+11.2%
564,7150.0%0.00%0.0%
Q1 2023$492
+54.7%
564,715
+68.7%
0.00%0.0%
Q4 2022$318
-99.9%
334,7040.0%0.00%0.0%
Q3 2022$366,000
-3.7%
334,704
+6.5%
0.00%0.0%
Q2 2022$380,000
+0.8%
314,334
+78.9%
0.00%0.0%
Q1 2022$377,000175,7210.00%
Other shareholders
ALIGOS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,320,381$2,808,0004.30%
Pivotal bioVenture Partners Investment Advisor LLC 743,215$899,0000.45%
Vivo Capital, LLC 3,547,030$4,292,0000.43%
TANG CAPITAL MANAGEMENT LLC 1,547,710$1,873,0000.28%
Newtyn Management, LLC 962,088$1,164,0000.22%
EcoR1 Capital, LLC 3,948,360$4,778,0000.16%
Boxer Capital, LLC 1,526,048$1,847,0000.12%
Novo Holdings A/S 1,950,000$2,360,0000.12%
HHLR ADVISORS, LTD. 2,365,064$2,862,0000.06%
SILVERARC CAPITAL MANAGEMENT, LLC 58,392$71,0000.02%
View complete list of ALIGOS THERAPEUTICS INC shareholders